BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22412050)

  • 1. Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Inatsugi N; Nonomura A
    J Clin Pathol; 2012 Jun; 65(6):522-7. PubMed ID: 22412050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
    Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
    Rena O; Boldorini LR; Gaudino E; Casadio C
    J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.
    Perrone F; Jocollè G; Pennati M; Deraco M; Baratti D; Brich S; Orsenigo M; Tarantino E; De Marco C; Bertan C; Cabras A; Bertulli R; Pierotti MA; Zaffaroni N; Pilotti S
    Eur J Cancer; 2010 Oct; 46(15):2837-48. PubMed ID: 20692828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma.
    Gaafar R; Bahnassy A; Abdelsalam I; Kamel MM; Helal A; Abdel-Hamid A; Eldin NA; Mokhtar N
    Lung Cancer; 2010 Oct; 70(1):43-50. PubMed ID: 20347505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
    Takeda M; Kasai T; Enomoto Y; Takano M; Morita K; Kadota E; Nonomura A
    Pathol Int; 2010 May; 60(5):395-9. PubMed ID: 20518890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor structural alterations in gastric cancer.
    Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
    BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.
    Cho KS; Lee JS; Cho NH; Park K; Ham WS; Choi YD
    Prostate; 2008 Jun; 68(8):803-8. PubMed ID: 18302229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
    Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
    Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
    Monaco SE; Shuai Y; Bansal M; Krasinskas AM; Dacic S
    Am J Clin Pathol; 2011 Apr; 135(4):619-27. PubMed ID: 21411785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
    Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
    Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor mutations in small cell lung cancer.
    Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
    Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.
    Okuda K; Sasaki H; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1105-11. PubMed ID: 18392851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.